SSY GROUP: DATE OF BOARD MEETING

HKEXAug 14 16:31 · Announcements

The National Development and Reform Commission (NDRC) convened a symposium on the development of the biopharmaceutical industry at the end of last month.

The Price Cost and Certification Center of the National Development and Reform Commission (NDRC) organized a symposium with selected domestic innovative biopharmaceutical companies on July 30 to gain insights into emerging trends, new challenges, and future development trajectories in the biopharmaceutical industry, and to solicit opinions and suggestions for subsequent research initiatives.

AASTOCKSAug 13 10:59

Interest in semiconductor industry research has been overtaken.

Recently, innovative pharmaceuticals have experienced a rebound, significantly boosting market interest in the pharmaceutical and biotechnology sector.

cls.cnAug 11 16:18

Double positive catalysts boost pharmaceutical stocks! Wuxi Apptec’s Hong Kong shares hit a record high.

① Wuxi Apptec has obtained a preliminary injunction shielding it from the immediate effects of a Section 1260H designation—what do industry insiders think? ② Against the backdrop of sustained strong BD deal activity in outbound innovative drug transactions, how do institutional investors view pharmaceutical stocks?

cls.cnAug 10 11:32

SSY Group Wins China Approval for New Antipsychotic Bulk Drug

TipRanksAug 7 19:15

Most innovative drug-related stocks rose, as innovative pharmaceutical companies enter their earnings announcement window, and upcoming academic conferences are expected to provide a series of catalysts.

According to data from the National Medical Products Administration (NMPA), China recorded 81 outbound licensing deals for innovative drugs in the first half of the year, with a total transaction value of approximately USD 110 billion—already reaching 80% of the full-year 2025 level and setting a new record high for a half-year period. Disclosure of clinical data at top-tier international medical conferences is expected to serve as a key near-term catalyst. The World Conference on Lung Cancer (WCLC) has already released abstract titles and will publish full data on August 19; meanwhile, the European Society of Cardiology (ESC) annual congress at the end of August will feature pivotal cardiovascular clinical trial results. Bohai Securities notes that August marks the semi-annual earnings reporting season and recommends prioritizing sectors likely to benefit from earnings-driven catalysts. Furthermore, the firm maintains a long-term positive outlook on the development trajectory of domestically developed innova

Zhitong FinanceAug 7 13:28